We are pleased to announce that PhysioAssist has signed an exclusive distribution agreement with PARI Medical Ltd regarding the commercialization of the Simeox device in the UK territory.
At PhysioAssist, our goal is to set Simeox as a standard of care therapy for the respiratory management of patients with obstructive pulmonary diseases such as cystic fibrosis, bronchiectasis, COPD and Primary Ciliary Dyskinesia. We proudly believe Simeox can greatly benefit those patients and are delighted that such a trusted company like PARI Medical Ltd has allied with us to drive awareness and adoption of Simeox therapy throughout the UK.
“At PARI, our mission is to improve the lives of those affected by respiratory diseases and those who provide care to them. This is reflected in our comprehensive portfolio of innovative products and services. Therefore we’re proud to have partnered with PhysioAssist in the UK to distribute their innovative Simeox device. We are confident that the combination of their innovation and our customer support will enable patients and healthcare professionals throughout the UK to benefit from this excellent device” says Mal Apter, Country Manager UK & Ireland at PARI Medical Ltd.
For further information, contact us at email@example.com